Nautilus Biotechnology, Inc. (NAUT) bonds
NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.36+0.26 (+12.38%)
Close on Nov 17, 2026Market cap $300.60MP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Nautilus Biotechnology reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Nautilus Biotechnology's 10-Q for the period ended Dec 31, 2021
Nautilus Biotechnology's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| San Carlos Lease Improvements Line of Credit | $2.00M |
See a number that looks wrong?